“… 36 Several other lesions have been reported for COVID‐19, some of which cannot be categorized into one of the mentioned groups. Examples include pityriasis rosea‐like rash, 37 Grover's disease‐like eruptions, 23 , 38 acro‐ischemia, 39 malar erythema, and facial edema, 40 palmar erythema, 41 symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE)‐like eruptions, 42 hand‐foot‐mouth‐like diseases, 24 “COVID toes” or pernio‐like eruptions, 43 Dengue‐like rashes, 33 diffuse melanoderma, 44 gangrene, 45 paronychia, 46 sacral and buttocks ulcerations, 47 mottling, 48 lichenoid eruptions, 49 drug reaction with eosinophilia and systemic symptom (DRESS), 50 acute generalized exanthematous pustulosis (AGEP), 51 Raynaud's phenomenon, 52 eruptive cherry angioma, 1 violaceous macules with “porcelain‐like” appearance, 53 IgA vasculitis, 54 leukocytoclastic vasculitis, 55 retiform purpura, eosinophilic panniculitis, 56 and periorbital dyschromia. 57 …”